SCHEMBL28672425

SCHEMBL28672425

O=P(O)(O)ON(c1ccccc1)P(=O)(O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
SRC P12931 3/20 0.43
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
CA5A P35218 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
KDM4E B2RXH2 1/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
PDE3A Q14432 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TSHR P16473 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
CFTR P13569 1/20 0.34
ATM Q13315 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21176803 0.78 MEN1 (0.48) MEN1HTTKMT2ASRCCA2
SCHEMBL29120368 0.78 SRC (0.47) MEN1HTTKMT2ASRCCA2
SCHEMBL2854023 0.75 HTT (0.56) MEN1HTTKMT2ASRCCA2
SCHEMBL3065169 0.75 MEN1 (0.54) MEN1HTTKMT2ASRCCA2
Methane SCHEMBL10783749 0.73 MEN1 (0.52) MEN1HTTKMT2ASRCCA2
SCHEMBL2855667 0.71 MEN1 (0.45) MEN1HTTKMT2ASRCALDH1A1
Aniline SCHEMBL9347211 0.71 TSHR (0.41) MEN1HTTKMT2ASRCCA2
SCHEMBL28485352 0.71 MEN1 (0.41) MEN1HTTKMT2ASRCCA2
SCHEMBL2309806 0.70 MEN1 (0.48) MEN1HTTKMT2ASRCCA2
SCHEMBL8530739 0.70 MEN1 (0.48) MEN1HTTKMT2ASRCCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110913871-B Generation of mammalian T cell activation inducible synthetic promoters (SYN+PRO) to improve T cell therapy 西雅图儿童医院(DBA西雅图儿童研究所) 2024-02-23 CN disclosed
CN-110381998-B anti-LAIR 1 antibodies and uses thereof 德克萨斯大学体系董事会 2023-08-29 CN disclosed
CN-109311966-B Trispecific and/or trivalent binding proteins for use in the prevention or treatment of HIV infection 赛诺菲 2023-03-10 CN disclosed
CN-107106611-B Compositions and methods for improving the efficacy of adoptive cellular immunotherapy 弗雷德哈钦森癌症研究中心 2021-11-23 CN disclosed